Cargando…

Celecoxib and Etoricoxib may reduce risk of ischemic stroke in patients with rheumatoid arthritis: A nationwide retrospective cohort study

BACKGROUND AND PURPOSE: Previous studies reported conflicting results about the risk of ischemic stroke associated with the use of non-steroidal anti-inflammatory drugs (NSAIDs) in patients with rheumatoid arthritis (RA). We aimed to investigate two specific COX-2 inhibitors, Celecoxib and Etoricoxi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Acer I-Hung, Lee, Yung-Heng, Perng, Wuu-Tsun, Chiou, Jeng-Yuan, Wang, Yu-Hsun, Lin, Lichi, Wei, James Cheng-Chung, Tsou, Hsi-Kai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630581/ https://www.ncbi.nlm.nih.gov/pubmed/36341096 http://dx.doi.org/10.3389/fneur.2022.1018521

Ejemplares similares

Methotrexate at middle and high accumulative doses might be associated with lower risk of new-onset cancers in patients with rheumatoid arthritis: a nationwide population-based cohort study
por: Perng, Wuu-Tsun, et al.
Publicado: (2020)

The effect of anti-rheumatic medications for coronary artery diseases risk in patients with rheumatoid arthritis might be changed over time: A nationwide population-based cohort study
por: Hung, Yao-Min, et al.
Publicado: (2017)

Cost-Effectiveness Evaluation of Etoricoxib versus Celecoxib and Nonselective NSAIDs in the Treatment of Ankylosing Spondylitis in Norway
por: Jansen, Jeroen P., et al.
Publicado: (2011)

A Comparison of Cardiovascular Biomarkers in Patients Treated for Three Months with Etoricoxib, Celecoxib, Ibuprofen, and Placebo
por: Cannon, Christopher P, et al.
Publicado: (2008)

Are All Oral COX-2 Selective Inhibitors the Same? A Consideration of Celecoxib, Etoricoxib, and Diclofenac
por: Walker, Chris
Publicado: (2018)

Efficacy of Etoricoxib, Celecoxib, Lumiracoxib, Non-Selective NSAIDs, and Acetaminophen in Osteoarthritis: A Mixed Treatment Comparison
por: Stam, WB, et al.
Publicado: (2012)

Erratum to “Are All Oral COX-2 Selective Inhibitors the Same? A Consideration of Celecoxib, Etoricoxib, and Diclofenac”
por: Walker, Chris
Publicado: (2019)

Protective Effect of Celecoxib on Early Postoperative Cognitive Dysfunction in Geriatric Patients
por: Zhu, Yangzi, et al.
Publicado: (2018)

Neoplasm Risk in Rheumatic Diseases Has No Correlation With Conventional Synthetic Disease-Modifying Anti-rheumatic Drugs Usage—A Population-Based Nested Case–Control Study
por: Cai, Shaozhe, et al.
Publicado: (2020)

Etoricoxib may inhibit cytokine storm to treat COVID-19
por: Wang, Ruo
Publicado: (2021)

Gastrointestinal safety of etoricoxib in osteoarthritis and rheumatoid arthritis: A meta-analysis
por: Feng, Xiaoting, et al.
Publicado: (2018)

Risk of primary Sjogren’s Syndrome following human papillomavirus infections: a nationwide population-based cohort study
por: Chen, Huang-Hsi, et al.
Publicado: (2022)

Patients With Rheumatoid Arthritis Increased Risk of Developing Osteoarthritis: A Nationwide Population-Based Cohort Study in Taiwan
por: Lee, Yung-Heng, et al.
Publicado: (2020)

Etoricoxib for arthritis and pain management
por: Brooks, Peter, et al.
Publicado: (2006)

The cardiovascular risks of etoricoxib (Arcoxia)
por: Sasich, Larry D., et al.
Publicado: (2008)

Comparing etoricoxib and celecoxib for preemptive analgesia for acute postoperative pain in patients undergoing arthroscopic anterior cruciate ligament reconstruction: a randomized controlled trial
por: Boonriong, Tanarat, et al.
Publicado: (2010)

Amyloid and tau PET in cerebral amyloid angiopathy-related inflammation two case reports and literature review
por: Yang, Jhih-Yong, et al.
Publicado: (2023)

A multinational randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis [ISRCTN25142273]
por: Collantes, Eduardo, et al.
Publicado: (2002)

Remote Ischemic Conditioning May Improve Disability and Cognition After Acute Ischemic Stroke: A Pilot Randomized Clinical Trial
por: Poalelungi, Alina, et al.
Publicado: (2021)

Etoricoxib-induced pretibial erythema and edema
por: Kumar, Pramod
Publicado: (2015)

Exantema fijo medicamentoso por etoricoxib
por: Cantero Macedo, Ana Margarita, et al.
Publicado: (2019)

Acupuncture May Decrease the Incidence of Post-stroke Dementia: A Taiwan Nationwide Retrospective Cohort Study
por: Chu, Shao-Ang, et al.
Publicado: (2021)

Admission Glucose Levels May Increase the Risk for Early Neurological Deterioration in Females With Acute Ischemic Stroke
por: Huang, Zhi-Xin, et al.
Publicado: (2020)

Severity of Lesions Involving the Cortical Cholinergic Pathways May Be Associated With Cognitive Impairment in Subacute Ischemic Stroke
por: Zhong, Huo-Hua, et al.
Publicado: (2021)

Epidemiologic Features, Survival, and Prognostic Factors Among Patients With Different Histologic Variants of Glioblastoma: Analysis of a Nationwide Database
por: Shieh, Li-Tsun, et al.
Publicado: (2021)

Dual-Antiplatelet Therapy May Not Be Associated With an Increased Risk of In-hospital Bleeding in Patients With Moderate or Severe Ischemic Stroke
por: Khazaal, Ossama, et al.
Publicado: (2021)

Radiomics features of DSC-PWI in time dimension may provide a new chance to identify ischemic stroke
por: Guo, Yingwei, et al.
Publicado: (2022)

Efficacy and Safety of Pregabalin Prolonged Release–Etoricoxib Combination Compared to Etoricoxib for Chronic Low Back Pain: Phase 3, Randomized Study
por: Yeole, Amit B., et al.
Publicado: (2022)

Impact of Rheumatoid Arthritis on Alopecia: A Nationwide Population-Based Cohort Study in Taiwan
por: Chang, Yi-Jung, et al.
Publicado: (2020)

Intravenous Thrombolysis May Not Improve Clinical Outcome of Acute Ischemic Stroke Patients Without a Baseline Vessel Occlusion
por: Tian, Huiqiao, et al.
Publicado: (2018)

Hyoid Elongation May Be a Rare Cause of Recurrent Ischemic Stroke in Youth-A Case Report and Literature Review
por: Liu, Gang, et al.
Publicado: (2021)

Automatic risk prediction of intracranial aneurysm on CTA image with convolutional neural networks and radiomics analysis
por: Xie, Yuan, et al.
Publicado: (2023)

Intravenous Thrombolysis Administration 3–4.5 h After Acute Ischemic Stroke: A Retrospective, Multicenter Study
por: Chen, Yu-Wei, et al.
Publicado: (2019)

Risk management profile of etoricoxib: an example of personalized medicine
por: Patrignani, Paola, et al.
Publicado: (2008)

The Effect of Etoricoxib on Hepatic Ischemia-Reperfusion Injury in Rats
por: Kunak, Celalettin Semih, et al.
Publicado: (2015)

A case report on toxic epidermal necrolysis with etoricoxib
por: Kameshwari, J. S., et al.
Publicado: (2015)

Seizure following the Use of the COX-2 Inhibitor Etoricoxib
por: Arnao, Valentina, et al.
Publicado: (2017)

Fixed drug eruption by etoricoxib confirmed by patch test
por: de Sousa, Aline Soares, et al.
Publicado: (2016)

Pachydermoperiostosis: a case report of initial improvement with etoricoxib
por: Vaidya, Nirish, et al.
Publicado: (2023)

Etoricoxib‐induced pleural effusion: A case report
por: Sah, Bishal Kumar, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0qtdgp1ijkodpnkvhfqjtan51i